AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
METHYLDOPA BP
3 registrations across 3 African markets— 2 active
Markets with METHYLDOPA BP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Hydopa Tablets Film Coated Tablets | 🇿🇲Zambia | LABORATORY & ALLIED LIMITED | active | Jul 2030 |
| M-DOPAKANT-250 Tablets | 🇷🇼Rwanda | S KANT HEALTHCARE LTD | active | Aug 2029 |
| METHYLDOPA_250 250MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2018 |
METHYLDOPA BP in Africa — Regulatory Overview
METHYLDOPA BP is registered across 3 African markets with 3 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Rwanda, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 3 registrations, 2 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.